Company Filing History:
Years Active: 2023-2025
Title: Lorena Lerner: Innovator in Oncolytic Viral Vectors
Introduction
Lorena Lerner is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer treatment through her innovative work on oncolytic viral vectors. With a total of 2 patents, her research focuses on harnessing the power of viruses to target and destroy cancer cells.
Latest Patents
Lerner's latest patents involve oncolytic viral vectors that incorporate several advanced features. These include viral replication restriction by inserting microRNA (miRNA) target sequences into the viral genome, disrupting oncogenic miRNA function, remodeling the cancer microenvironment, and targeting cancer cells by incorporating protease-activated antibodies into the viral particle. Such viral vectors are designed for the treatment and prevention of cancer, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Lorena Lerner has worked with notable companies such as Oncorus, Inc. and Virogin Biotech Canada Ltd. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Lerner has collaborated with esteemed colleagues, including Mitchell H. Finer and Christophe Quéva. These partnerships have further enriched her work and expanded the impact of her innovations in cancer treatment.
Conclusion
Lorena Lerner's contributions to the field of oncolytic viral vectors represent a significant advancement in cancer therapy. Her innovative approach and dedication to research continue to inspire progress in the fight against cancer.